ResMed, Inc. (RMD)

259.12 +2.83 (+1.10%) USD  |  NYSE  |  Feb 20, 16:00
259.14 +0.02 (+0.01%) After-Hours: 20:00
More

ResMed Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Abbott Laboratories Upgrade
Baxter International, Inc. Upgrade
Stryker Corp. Upgrade
Globus Medical, Inc. Upgrade